Trials / Unknown
UnknownNCT02547350
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Xuesong Li · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of prophylactic intravesical chemotherapy (different chemotherapy drugs and dosage regimen) in the prevention of bladder recurrence after nephroureterectomy for upper tract urothelial carcinoma (UTUC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pharmorubicin or pirarubicin | pharmorubicin 50mg pirarubicin 30mg |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2020-12-01
- First posted
- 2015-09-11
- Last updated
- 2015-09-11
Source: ClinicalTrials.gov record NCT02547350. Inclusion in this directory is not an endorsement.